A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China

Clinical trial NCT06422663 · COMPLETED

Trial details

NCT number: NCT06422663
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Moderate-to-Severe Asthma

Start date: 2024-03-22
Primary completion: 2025-03-13
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.